 |
市场调查报告书
商品编码
1707361
全球生物成像市场（按成像方式、最终用户和地区划分）Global Bio-imaging Market, By Imaging Modality, By End User, By Geography |
||||||
2025 年全球生物成像市场价值估计为 80.7 亿美元，预计到 2032 年将达到 221.3 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 15.5%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 80.7亿美元 |
| 效能数据 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025-2032年复合年增长率： | 15.50% | 2032年价值预测 | 221.3亿美元 |
生物成像是一项强大而重要的技术，广泛应用于生物学和医学领域。它是指从分子层次到器官层次获取、处理和可视化生物系统结构和功能资讯的技术集合。生物影像的主要目标是更深入地了解复杂的生物过程，促进准确的医学诊断，并指南介入和治疗。生物影像利用多种技术，包括X射线、磁振造影（MRI）、正子断层扫描（PET）、超音波和光学显微镜，为了解生物体内部运作提供了一个非侵入性的窗口。它们使研究人员和临床医生能够即时观察细胞和组织内的复杂相互作用，为现代诊断和疾病机制研究奠定了基石。最近的进展将生物成像的前沿扩展到奈米级，从而能够即时追踪细胞和分子事件。超高解析度显微镜、光声成像和生物发光等技术正在揭示前所未有的细节，并提高我们对与健康和疾病相关的生物途径的理解。生物成像从根本上来说是一个跨学科领域，涵盖物理学、工程学、生物学、化学、电脑科学和医学。它需要整合高解析度成像设备、先进的影像分析软体以及对底层生物过程的深入了解。在应用中，生物成像对于实验室和医疗保健环境至关重要。它有助于早期发现疾病，提高手术精度，并有助于开发标靶药物疗法。随着成像技术的不断发展，它有望透过考虑到每个患者个体生物学特征的客製化治疗方法彻底改变个人化医疗。因此，生物成像处于科学进步的前沿，弥合了基础研究与临床应用之间的差距，并推动了未来医疗保健创新的发展。
市场动态：
预计全球生物成像市场将在预测期内出现强劲增长，这归因于老年人口增加、慢性病和文明病患病率增加、诊断成像方式的技术进步以及医疗保健支出增加等因素。然而，与生物成像系统、程序和放射性示踪剂相关的高成本仍然是一个重大挑战。此外，有关辐射暴露的多项指导方针和法规也限制了市场。然而，新兴国家尚未开发的商业机会很可能在不久的将来为市场相关人员开闢新的途径。
本研究的主要特点
- 本报告对全球生物成像市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率(CAGR)。
- 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
- 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球生物成像市场的主要企业概况。
- 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
- 全球生物成像市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
- 相关人员将透过用于分析全球生物成像市场的各种策略矩阵来做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 成像技术的进展
- 限制因素
- 高资本投资要求
- 机会
- 混合成像系统
- 主要亮点
- 监管情景
- 近期动态
- PEST分析
- 波特分析
- 合併、收购和合作
第四章全球生物影像市场-冠状病毒（COVID-19）大流行的影响
- COVID-19流行病学
- 供需侧分析
- 经济影响
5. 2020 年至 2032 年全球生物影像市场（依影像方式划分）
- 磁振造影（MRI）
- 电脑断层扫描（CT）
- 正子断层扫描（PET）
- 超音波
- X射线
- 其他的
6. 2020 年至 2032 年全球生物影像市场（依最终用户划分）
- 医院和诊断中心
- 学术研究所
- 製药和生物技术公司
- 其他的
7. 2020-2032 年全球生物影像市场（按地区）
- 北美洲
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东
- 非洲
第八章 竞争态势
- 公司简介
- Bracco Imaging SPA
- Bayer HealthCare Pharmaceuticals
- Esaote SpA
- Digirad Corporation
- FONAR Corporation
- GE Healthcare
- Hologic Inc
- Hitachi Medical Corporation
- Lantheus Medical Imaging, Inc.
- Covidien Pharmaceuticals
- Mindray Medical International Limited.
- Gamma Medica Inc
- Samsung Medison Co., Ltd.
- Philips Healthcare
第九章 章节
- 参考
- 调查方法
- 关于出版商
Global Bio-imaging Market is estimated to be valued at USD 8.07 Bn in 2025 and is expected to reach USD 22.13 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 8.07 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 15.50% | 2032 Value Projection: | USD 22.13 Bn |
Bio-imaging is a powerful and essential technique that is widely used in the realm of biological and medical sciences. It refers to the ensemble of technologies that capture, process, and visualize structural and functional information of biological systems, ranging from the molecular to the organ level. The primary goal of bio-imaging is to gain a deeper understanding of complex biological processes, facilitate accurate medical diagnoses, and guide interventions and therapies. By leveraging diverse technologies such as X-ray, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, and optical microscopy, bio-imaging provides a non-invasive window into the inner workings of living organisms. It allows researchers and clinicians to observe the intricate interactions within cells and tissues in real-time, thereby making it a cornerstone in modern diagnostics and research on disease mechanisms. Recent advancements have expanded the frontiers of bio-imaging to nano-scale dimensions and have enabled real-time tracking of cellular and molecular events. Techniques such as super-resolution microscopy, photo acoustic imaging, and bioluminescence have brought unprecedented details to light, deepening our comprehension of biological pathways involved in health and disease. Fundamentally interdisciplinary, bio-imaging encompasses physics, engineering, biology, chemistry, computer science, and medicine. It demands the integration of high-resolution imaging instruments, sophisticated software for image analysis, and a profound knowledge of the underlying biological processes. In terms of its applications, bio-imaging is indispensable in research laboratories and healthcare settings. It aids in the early detection of diseases, enhances the precision of surgical procedures, and contributes to the development of targeted drug therapies. As bio-imaging technology continues to evolve, it promises to revolutionize personalized medicine by enabling a tailored approach to treatment that considers the unique biological makeup of each patient. Thus, bio-imaging stands at the forefront of scientific progress, bridging the gap between basic research and clinical application, and driving the future of healthcare innovations.
Market Dynamics:
Global bio-imaging market is expected to witness robust growth over the forecast period, due to several factors such as rising geriatric population, increasing incidence of chronic and lifestyle diseases, technological advancements in imaging modalities, and growing healthcare expenditure. However, high costs that are associated with bio-imaging systems, procedures, and radiotracers remain a major challenge. Several guidelines and regulations pertaining to radiation exposure also act as a restraint for the market. Nevertheless, untapped opportunities in emerging economies are likely to create new avenues for market players in the near future.
Key features of the study:
- This report provides an in-depth analysis of the global bio-imaging market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global bio-imaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc, Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc, Samsung Medison Co., Ltd., and Philips Healthcare.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global bio-imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analysing the global bio-imaging market
Detailed Segmentation:
- Global Bio-imaging Market Segmentation, By Imaging Modality:
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Position Emission Tomography (PET)
- Ultrasound
- X-ray
- Others
- Global Bio-imaging Market Segmentation, By End User:
- Hospitals & diagnostic centers
- Academic & research institutes
- Pharmaceutical & biotech companies
- Others
- Global Bio-imaging Market Segmentation, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles
- Bracco Imaging S.P.A
- Bayer HealthCare Pharmaceuticals
- Esaote S.p.A
- Digirad Corporation
- FONAR Corporation
- GE Healthcare
- Hologic Inc
- Hitachi Medical Corporation
- Lantheus Medical Imaging, Inc.
- Covidien Pharmaceuticals
- Mindray Medical International Limited.
- Gamma Medica Inc
- Samsung Medison Co., Ltd.
- Philips Healthcare
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Bio-imaging, By Imaging Modality
- Market Bio-imaging, By End User
- Market Bio-imaging, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Technological advancements in bio-imaging modalities
- Restraints
- High capital investment requirements
- Opportunities
- Hybrid imaging systems
- Key Highlights
- Regulatory Scenario
- Recent Trends
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Bio-imaging Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Bio-imaging Market, By Imaging Modality, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Magnetic Resonance Imaging (MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Computed Tomography (CT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Position Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Ultrasound
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- X-ray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
6. Global Bio-imaging Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals & diagnostic centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Academic & research institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Pharmaceutical & biotech companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
7. Global Bio-imaging Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020 -2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Company Profile
- Bracco Imaging S.P.A
- Company Highlights
- Imaging Modality Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer HealthCare Pharmaceuticals
- Esaote S.p.A
- Digirad Corporation
- FONAR Corporation
- GE Healthcare
- Hologic Inc
- Hitachi Medical Corporation
- Lantheus Medical Imaging, Inc.
- Covidien Pharmaceuticals
- Mindray Medical International Limited.
- Gamma Medica Inc
- Samsung Medison Co., Ltd.
- Philips Healthcare
- Analyst Views
9. Section
- References
- Research Methodology
- About us
